Annual Cash & Cash Equivalents
$78.82 M
-$29.80 M-27.43%
December 31, 2023
Summary
- As of February 6, 2025, LFST annual cash & cash equivalents is $78.82 million, with the most recent change of -$29.80 million (-27.43%) on December 31, 2023.
- During the last 3 years, LFST annual cash & cash equivalents has risen by +$59.99 million (+318.63%).
- LFST annual cash & cash equivalents is now -46.75% below its all-time high of $148.03 million, reached on December 31, 2021.
Performance
LFST Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$102.61 M
+$15.65 M+17.99%
September 30, 2024
Summary
- As of February 6, 2025, LFST quarterly cash and cash equivalents is $102.61 million, with the most recent change of +$15.65 million (+17.99%) on September 30, 2024.
- Over the past year, LFST quarterly cash and cash equivalents has increased by +$60.01 million (+140.85%).
- LFST quarterly cash and cash equivalents is now -62.85% below its all-time high of $276.19 million, reached on June 30, 2021.
Performance
LFST Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
LFST Cash And Cash Equivalents Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -27.4% | +140.8% |
3 y3 years | +318.6% | -5.5% |
5 y5 years | +2164.4% | -5.5% |
LFST Cash And Cash Equivalents Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -46.8% | at low | -30.7% | +140.8% |
5 y | 5-year | -46.8% | +2164.4% | -62.9% | +445.0% |
alltime | all time | -46.8% | +2164.4% | -62.9% | +445.0% |
LifeStance Health Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $102.61 M(+18.0%) |
Jun 2024 | - | $86.97 M(+75.9%) |
Mar 2024 | - | $49.45 M(-37.3%) |
Dec 2023 | $78.82 M(-27.4%) | $78.82 M(+85.0%) |
Sep 2023 | - | $42.60 M(-46.5%) |
Jun 2023 | - | $79.61 M(+16.6%) |
Mar 2023 | - | $68.29 M(-37.1%) |
Dec 2022 | $108.62 M | $108.62 M(+20.2%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2022 | - | $90.34 M(-6.6%) |
Jun 2022 | - | $96.69 M(-15.2%) |
Mar 2022 | - | $113.99 M(-23.0%) |
Dec 2021 | $148.03 M(+686.2%) | $148.03 M(-30.2%) |
Sep 2021 | - | $212.12 M(-23.2%) |
Jun 2021 | - | $276.19 M(+599.3%) |
Mar 2021 | - | $39.49 M(+109.8%) |
Dec 2020 | $18.83 M(+440.9%) | $18.83 M |
Dec 2019 | $3.48 M | - |
FAQ
- What is LifeStance Health annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for LifeStance Health?
- What is LifeStance Health annual cash & cash equivalents year-on-year change?
- What is LifeStance Health quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for LifeStance Health?
- What is LifeStance Health quarterly cash and cash equivalents year-on-year change?
What is LifeStance Health annual cash & cash equivalents?
The current annual cash & cash equivalents of LFST is $78.82 M
What is the all time high annual cash & cash equivalents for LifeStance Health?
LifeStance Health all-time high annual cash & cash equivalents is $148.03 M
What is LifeStance Health annual cash & cash equivalents year-on-year change?
Over the past year, LFST annual cash & cash equivalents has changed by -$29.80 M (-27.43%)
What is LifeStance Health quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of LFST is $102.61 M
What is the all time high quarterly cash and cash equivalents for LifeStance Health?
LifeStance Health all-time high quarterly cash and cash equivalents is $276.19 M
What is LifeStance Health quarterly cash and cash equivalents year-on-year change?
Over the past year, LFST quarterly cash and cash equivalents has changed by +$60.01 M (+140.85%)